Carregant...
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
BACKGROUND: Although sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival. METHODS: A retrospective study of sorafenib-treated patients with advanced HCC was conduc...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342054/ https://ncbi.nlm.nih.gov/pubmed/27494871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11030 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|